Vontobel Holding Ltd. Eye Point Pharmaceuticals, Inc. Transaction History

Vontobel Holding Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jun 03, 2024	SELL	$7.99 - $15.36 $1.12 Million - $2.15 Million	-139,923 Reduced 44.28%	176,080 $1.41 Million
Q3 2023 Oct 10, 2023	SELL	$7.99 - $15.36 $1.12 Million - $2.15 Million	-139,923 Reduced 44.28%	176,080 $1.41 Million
Q2 2023 Jun 03, 2024	BUY	$3.03 - $9.0 $898,813 - $2.67 Million	296,638 Added 1531.83%	316,003 $2.75 Million
Q2 2023 Jul 24, 2023	BUY	$3.03 - $9.0 $898,813 - $2.67 Million	296,638 Added 1531.83%	316,003 $2.75 Million
Q1 2023 Jun 03, 2024	BUY	$2.28 - $5.04 $44,152 - $97,599	19,365 New	19,365 $56,000
Q1 2023 Apr 12, 2023	BUY	$2.28 - $5.04 $44,152 - $97,599	19,365 New	19,365 $56,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $312M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.